Unknown
38 stocks in Healthcare & Pharma.
Company snapshot 2026-11-13 · Calculated market cap as of 2026-11-06 · USD
| Ticker | Company | Market Cap | Revenue (TTM) | Net Income (TTM) |
|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | $10.22B | — | −$294.37MTTM ended 2026-06-30 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.01B | $42.16MTTM ended 2026-06-30 | −$501.61MTTM ended 2026-06-30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $3.16B | $865.11MTTM ended 2026-09-30 | −$43.86MTTM ended 2026-09-30 |
| ATAI | AtaiBeckley Inc. | $2.73B | $4.47MTTM ended 2026-06-30 | −$668.19MTTM ended 2026-06-30 |
| BLFS | BIOLIFE SOLUTIONS INC | $1.89B | $106.69MTTM ended 2026-06-30 | $57.98MTTM ended 2026-06-30 |
| FBRX | Forte Biosciences, Inc. | $1.63B | — | −$87.94MTTM ended 2026-06-30 |
| KALV | KalVista Pharmaceuticals, Inc. | $1.44B | — | −$203.10MTTM ended 2025-07-31 |
| TBPH | Theravance Biopharma, Inc. | $884.18M | $104.31MTTM ended 2026-06-30 | $53.81MTTM ended 2026-06-30 |
| TALK | Talkspace, Inc. | $870.58M | $245.73MTTM ended 2026-06-30 | $194.00KTTM ended 2026-06-30 |
| ASRT | Assertio Holdings, Inc. | $151.86M | $102.16MTTM ended 2026-03-31 | −$35.69MTTM ended 2026-03-31 |
| DXR | DAXOR CORP | $36.21M | — | — |
| OSRH | OSR Holdings, Inc. | $5.09M | $1.81MTTM ended 2026-06-30 | −$14.91MTTM ended 2026-06-30 |
| GCTK | Glucotrack, Inc. | $4.02M | — | −$15.95MTTM ended 2026-06-30 |
| BCAB | BioAtla, Inc. | $3.48M | — | −$31.45MTTM ended 2026-06-30 |
| FEED | ENvue Medical, Inc. | $2.88M | $1.93MTTM ended 2026-06-30 | −$21.06MTTM ended 2026-06-30 |
| BTAI | BioXcel Therapeutics, Inc. | $2.32M | $742.00KTTM ended 2026-06-30 | −$70.86MTTM ended 2026-06-30 |
| SNYR | Synergy CHC Corp. | $1.35M | $27.70MTTM ended 2026-03-31 | −$15.79MTTM ended 2026-03-31 |
| LNAI | Lunai Bioworks Inc. | $829.68K | $51.99KTTM ended 2026-06-30 | −$3.56MTTM ended 2026-06-30 |
| VSEE | VSEE HEALTH, INC. | $814.77K | $14.46MTTM ended 2026-03-31 | −$13.35MTTM ended 2026-03-31 |
| MEHA | Functional Brands Inc. | $136.33K | $6.67MTTM ended 2026-03-31 | −$6.11MTTM ended 2026-03-31 |
| ADTX | Aditxt, Inc. | $815.92 | $14.34KTTM ended 2026-03-31 | −$53.34MTTM ended 2026-03-31 |
| ACLX | Arcellx Inc. | — | $22.29MTTM ended 2025-12-31 | −$228.93MTTM ended 2025-12-31 |
| ADRX | ADARx Pharmaceuticals, Inc. | — | — | — |
| AVNS | AVANOS MEDICAL, INC. | — | $715.90MTTM ended 2026-03-31 | −$74.40MTTM ended 2026-03-31 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | — | $596.96MTTM ended 2026-03-31 | $221.32MTTM ended 2026-03-31 |
| CTY | CITY THERAPEUTICS, INC. | — | — | — |
| ESPR | Esperion Therapeutics, Inc. | — | $418.24MTTM ended 2026-03-31 | −$7.42MTTM ended 2026-03-31 |
| ETRA | Electra Therapeutics, Inc. | — | — | — |
| FONR | FONAR CORP | — | $105.34MTTM ended 2026-03-31 | $6.69MTTM ended 2026-03-31 |
| IAM | Iambic Therapeutics, Inc. | — | — | — |
| LYCA | Lycia Therapeutics, Inc. | — | — | — |
| MASI | MASIMO CORP | — | $1.56BTTM ended 2026-04-04 | $76.30MTTM ended 2026-04-04 |
| NOTV | Inotiv, Inc. | — | $507.36MTTM ended 2026-03-31 | −$86.97MTTM ended 2026-03-31 |
| NUVL | Nuvalent, Inc. | — | — | −$450.07MTTM ended 2026-03-31 |
| RTSN | Retension Pharmaceuticals, Inc. | — | — | — |
| SEM | SELECT MEDICAL HOLDINGS CORP | — | $5.52BTTM ended 2026-03-31 | $133.53MTTM ended 2026-03-31 |
| TRXB | TRex Bio, Inc. | — | — | — |
| XOMA | XOMA Royalty Corp | — | $48.55MTTM ended 2026-03-31 | $33.81MTTM ended 2026-03-31 |
No matching companies.